Drug Delivery Technologies
Posted in Labels: Drug Delivery Technologies, DrugDeliveryTechnologies, Drugs, Players, products and prospects to 2018Drug Delivery Technologies:
Critical analyses and competitive ratings for major specialist developers
Unique sales forecasts to 2018 for key current and new products utilising drug delivery technologies
A comprehensive examination of the 4 major and compelling drug delivery sectors
While pharmaceutical sales have risen steadily over the last five years generating over US$720 billion in 2008, analysts are forecasting sales growth will slow over the next five years due to an unprecedented level of patent expiration compounded by the downturn in the global economy. At the same time, the global drug delivery market has undergone rapid growth from an estimated US$26 billion in 2000 to approximately US$74 billion in 2008.
This market has been driven by a number of factors:
Advances in new delivery technology (microencapsulation, nanotechnology);
Development and cost-effective manufacture of new delivery materials (dendrimers, lipid formulations and biodegradable polymers);
Emergence of new delivery specialists expanding the availability of delivery platforms e.g. siRNA delivery;
Patent expiration of leading brands forcing the pharmaceutical industry to evaluate ways to maximise product lifecycles through new formulations, combinations and repositioning;
Renewed interest in the development of novel biologics and vaccines requiring specialised delivery technologies;
Dramatic growth reflected in the evolution of an array of delivery vehicles and hybrid platforms that are increasingly being used to deliver approved and novel therapeutic agents.
Within this market there are areas of advanced drug delivery which have attracted the attention of the pharmaceutical industry and the investment community.
Focusing on the sectors that are driving growth!
VOLUME I
CONTROLLED- RELEASE
VOLUME II
NANOTECHNOLOGY
VOLUME III
NUCLEIC ACID DELIVERY
VOLUME IV
TARGETED DELIVERY
Buy Now: Market Research
Browse All: Drug Delivery Technologies Market
Browse All: Drug Delivery Market
Players, products & prospects to 2018
Critical analyses and competitive ratings for major specialist developers
Unique sales forecasts to 2018 for key current and new products utilising drug delivery technologies
A comprehensive examination of the 4 major and compelling drug delivery sectors
While pharmaceutical sales have risen steadily over the last five years generating over US$720 billion in 2008, analysts are forecasting sales growth will slow over the next five years due to an unprecedented level of patent expiration compounded by the downturn in the global economy. At the same time, the global drug delivery market has undergone rapid growth from an estimated US$26 billion in 2000 to approximately US$74 billion in 2008.
This market has been driven by a number of factors:
Development and cost-effective manufacture of new delivery materials (dendrimers, lipid formulations and biodegradable polymers);
Emergence of new delivery specialists expanding the availability of delivery platforms e.g. siRNA delivery;
Patent expiration of leading brands forcing the pharmaceutical industry to evaluate ways to maximise product lifecycles through new formulations, combinations and repositioning;
Renewed interest in the development of novel biologics and vaccines requiring specialised delivery technologies;
Dramatic growth reflected in the evolution of an array of delivery vehicles and hybrid platforms that are increasingly being used to deliver approved and novel therapeutic agents.
Within this market there are areas of advanced drug delivery which have attracted the attention of the pharmaceutical industry and the investment community.
Focusing on the sectors that are driving growth!
VOLUME I
CONTROLLED- RELEASE
VOLUME II
NANOTECHNOLOGY
VOLUME III
NUCLEIC ACID DELIVERY
VOLUME IV
TARGETED DELIVERY
Buy Now: Market Research
Browse All: Drug Delivery Technologies Market
Browse All: Drug Delivery Market
